Management of Benign Rectal Neoplasms
For benign rectal polyps, piecemeal endoscopic mucosal resection (pEMR) is the preferred first-line treatment because it achieves equivalent cure rates with lower morbidity (13% vs 24%), shorter hospital stays (0 vs 3 days), and substantially lower costs ($2,000 vs $7,800) compared to transanal endoscopic microsurgery (TEMS). 1
Endoscopic Resection as Primary Approach
pEMR should be attempted first for most benign rectal polyps because it provides definitive removal with superior cost-effectiveness and reduced complications compared to surgical alternatives. 1
Late recurrence rates after pEMR are similar to TEMS (13.8% vs 9.6%, p=0.386) when allowing for repeat endoscopic therapy during surveillance, making the higher morbidity and cost of TEMS unjustifiable for most lesions. 2, 1
High-definition endoscopy must assess for features suggesting deep submucosal invasion (irregular surface, ulceration, firmness, failure to lift after submucosal injection) because these findings preclude safe endoscopic resection. 1
When to Consider Transanal Endoscopic Microsurgery (TEMS)
TEMS may be selected as first-line treatment in specific scenarios:
Polyps occupying significant rectal circumference (>50% of lumen) where snare retrieval is technically difficult due to soft texture. 2, 1
Lesions with high bleeding risk during endoscopic resection due to location or vascularity. 2
TEMS achieves superior en bloc resection rates (98.7% vs 87.8% for endoscopic submucosal dissection) and curative resection rates (88.5% vs 74.6%), which may justify its use for complex lesions despite higher morbidity. 2, 1
Postoperative complications occur in 14-24% of TEMS cases, with median hospitalization of 3 days, compared to 8-13% complications and same-day discharge for pEMR. 2, 3, 4
Surgical Resection for Unresectable Lesions
When endoscopic and transanal approaches are not feasible:
Laparoscopic surgery is strongly preferred over open surgery because it reduces 30-day mortality (OR=0.57, p<0.001) and 365-day mortality (OR=0.53, p<0.001). 2, 1
Laparoscopic approaches accelerate recovery with earlier return of bowel function (3.7 vs 4.4 days, p<0.001) and shorter hospital stays (4.4 vs 8.0 days, p<0.001). 2
Surgical resection carries 20-30% morbidity and 0.6-3.2% mortality, making it appropriate only when minimally invasive options have failed or are contraindicated. 1
Surveillance After Endoscopic Resection
Schedule repeat endoscopy at 3-6 months after piecemeal resection of large lesions to detect residual tissue early, as initial recurrence rates reach 31% but most are successfully managed endoscopically. 2, 1
Transanal excision of large villous adenomas requires regular long-term follow-up because recurrence rates of 27-30% are expected even after apparently complete resection. 5
Critical Pitfalls to Avoid
Never attempt piecemeal resection if malignancy is suspected because fragmentation compromises pathological assessment of invasion depth, margins, and lymphovascular involvement. 1
Do not perform routine pre-operative biopsy of suspected malignant polyps, as it rarely changes management and introduces sampling error. 1
Avoid referring benign polyps directly to surgery without attempting endoscopic resection, as this exposes patients to unnecessary surgical mortality risk (0.6-3.2%). 1
TEMS should not be routinely chosen over pEMR based solely on early recurrence rates, because late recurrence rates equalize and TEMS carries double the morbidity. 2, 1